At recommended doses, glutathione stores remain sufficient
GLP-1R/GIPR agonist-1 can be used in the study of metabolic diseases such as diabetes, obesity, and non-alcoholic steatohepatitis (NASH)
discussion 2523S-4S
L-carnitine is best seen as an adjunctive tool that can support recovery and help preserve lean mass, not a standalone weight-loss medication
Abbreviations AE: Adverse event BMI: Body mass index CFR: Code of Federal Regulations CI: Confidence interval CSF: Cerebrospinal fluid EHR: Electronic health record GI: Gastrointestinal GIP: Glucosedependent insulinotropic polypeptide GLP-1: Glucagonlike peptide-1 GLP-1 RA: GLP-1 receptor agonist GRADE: Grading of Recommendations, Assessment, Development and Evaluations ICD-10: International Classification of Diseases, 10th Revision ICP: Intracranial pressure IIH: Idiopathic intracranial hypertension IQR: Interquartile range NKCC1: NaKCl cotransporter 1 OCT: Optical coherence tomography ONSF: Optic nerve sheath fenestration OR: Odds ratio PMD: Perimetric mean deviation PRISMA: Preferred Reporting Items for Systematic Reviews and MetaAnalyses RA: Receptor agonist RCT: Randomized controlled trial RNFL: Retinal nerve fiber layer ROBINS-I: Risk Of Bias In Nonrandomized Studies of Interventions RR: Risk ratio SAE: Serious adverse event SD: Standard deviation References Mollan SP, Grech O, Alimajstorovic Z et al (2020) New horizons for idiopathic intracranial hypertension: advances and challenges
The gradual titration schedule is evidence-based and designed to optimize both efficacy and tolerability over the full treatment course
